Literature DB >> 20339981

Strategies for treating liver metastasis from gastric cancer.

Yoshihiro Kakeji1, Masaru Morita, Yoshihiko Maehara.   

Abstract

The prognosis of patients with liver metastasis from gastric cancer is dismal. This article reviews the characteristics of gastric cancer metastasizing to the liver, and multimodality of treatments. Differentiated adenocarcinoma, poorly differentiated adenocarcinoma with a medullary growth pattern, and special types, including endocrine carcinoma and hepatoid carcinoma, are likely to metastasize to the liver. The overexpression of growth factors or adhesion molecules is clinically significant for liver metastasis. Surgery for liver metastases arising from gastric adenocarcinoma is reasonable if a complete resection seems feasible after careful preoperative staging. A hepatic resection should always be considered as an option for gastric cancer patients with hepatic metastases. Newer generation cytotoxic agents such as S-1, irinotecan, and taxanes show promising activity for patients with metastases. Adjuvant chemotherapy or molecular targeted therapy will provide significant benefits to patients in the future.

Entities:  

Mesh：

Year:  2010        PMID： 20339981     DOI： 10.1007/s00595-009-4152-0

Source DB:  PubMed          Journal:  Surg Today        ISSN： 0941-1291            Impact factor:   2.549


  81 in total

1.  Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Haruyuki Takaki; Yasuhiro Mori; Hitoshi Tonouchi; Masato Kusunoki; Hideya Kida; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2005-12       Impact factor: 3.464

2.  Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer.

Authors:  T Kumada; Y Arai; K Itoh; Y Takayasu; K Nakamura; Y Ariyoshi; K Tajima
Journal:  Oncology       Date:  1999-10       Impact factor: 2.935

3.  Benefits and limits of hepatic resection for gastric metastases.

Authors:  S Ambiru; M Miyazaki; H Ito; K Nakagawa; H Shimizu; H Yoshidome; Y Shimizu; N Nakajima
Journal:  Am J Surg       Date:  2001-03       Impact factor: 2.565

4.  The possible role of radiofrequency as complementary treatment of locally advanced gastric cancer.

Authors:  A Carditello; C Scisca; F Stilo; A Parisi; M Basile
Journal:  Ann Ital Chir       Date:  2005 Jan-Feb       Impact factor: 0.766

5.  Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Authors:  Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

6.  Predictive value of preoperative serum sialyl Tn antigen levels in prognosis of patients with gastric cancer.

Authors:  I Takahashi; Y Maehara; T Kusumoto; M Yoshida; Y Kakeji; H Kusumoto; M Furusawa; K Sugimachi
Journal:  Cancer       Date:  1993-09-15       Impact factor: 6.860

7.  Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.

Authors:  Ken Shirabe; Mitsuo Shimada; Takashi Matsumata; Hidefumi Higashi; Yohichi Yakeishi; Shigeki Wakiyama; Yasuharu Ikeda; Takuhiro Ezaki; Shingo Fukuzawa; Kenji Takenaka; Keishi Kishikawa; Tetsuo Ikeda; Ken-ichi Taguchi; Yoshihiko Maehara; Keizo Sugimachi
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

8.  Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases.

Authors:  Y Yonemura; N Matuki; H Sakuma; K Katayama; T Sawa; T Fujimura; S Ohyama; K Miwa; I Miyazaki; M Tanaka
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

9.  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors:  David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

Review 10.  Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions.

Authors:  K Matsumoto; T Nakamura
Journal:  Crit Rev Oncog       Date:  1992
View more
  30 in total

1.  Radiosurgery for liver metastases. A single institution experience.

Authors:  Beatriz Amendola; Marco Amendola; Jesús M Blanco; Naipy Perez; Xiaodong Wu
Journal:  Rep Pract Oncol Radiother       Date:  2016-12-21

2.  Conversion therapy for inoperable advanced gastric cancer patients by docetaxel, cisplatin, and S-1 (DCS) chemotherapy: a multi-institutional retrospective study.

Authors:  Yasushi Sato; Hiroyuki Ohnuma; Takayuki Nobuoka; Masahiro Hirakawa; Tamotsu Sagawa; Koshi Fujikawa; Yasuo Takahashi; Minami Shinya; Shinich Katsuki; Minoru Takahashi; Masahiro Maeda; Yutaka Okagawa; Uemura Naoki; Syouhei Kikuch; Koichi Okamoto; Hiroshi Miyamoto; Mitsuo Shimada; Ichiro Takemasa; Junji Kato; Tetsuji Takayama
Journal:  Gastric Cancer       Date:  2016-08-23       Impact factor: 7.370

3.  Long-term survival following radical surgery after chemotherapy for esophagogastric adenocarcinoma with extensive lymph node metastases: report of a case.

Authors:  Yoshiro Aoki; Yasushi Toh; Junya Taomoto; Yoshihisa Sakaguchi; Takeshi Okamura
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

4.  Survival benefit of surgical treatment for liver metastases from gastric cancer.

Authors:  Toshiki Shinohara; Yoshiaki Maeda; Tomonori Hamada; Noriaki Futakawa
Journal:  J Gastrointest Surg       Date:  2015-02-19       Impact factor: 3.452

5.  Outcome of operative therapy of hepatic metastatic stomach carcinoma: a retrospective analysis.

Authors:  Claus W Schildberg; R Croner; S Merkel; V Schellerer; V Müller; S Yedibela; W Hohenberger; G Peros; A Perrakis
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

Review 6.  Treatment of gastric cancer.

Authors:  Michele Orditura; Gennaro Galizia; Vincenzo Sforza; Valentina Gambardella; Alessio Fabozzi; Maria Maddalena Laterza; Francesca Andreozzi; Jole Ventriglia; Beatrice Savastano; Andrea Mabilia; Eva Lieto; Fortunato Ciardiello; Ferdinando De Vita
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

Review 7.  The role of surgery in the therapeutic approach of gastric cancer liver metastases.

Authors:  Aikaterini Mastoraki; Christina Benetou; Sotiria Mastoraki; Ioannis S Papanikolaou; Nikolaos Danias; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Indian J Gastroenterol       Date:  2016-08-16

8.  Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation.

Authors:  Ali Guner; Taeil Son; In Cho; In Gyu Kwon; Ji Yeong An; Hyoung-Il Kim; Jae-Ho Cheong; Sung Hoon Noh; Woo Jin Hyung
Journal:  Gastric Cancer       Date:  2015-08-01       Impact factor: 7.370

9.  Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302).

Authors:  Eiji Oki; Shoji Tokunaga; Yasunori Emi; Tetsuya Kusumoto; Manabu Yamamoto; Kengo Fukuzawa; Ikuo Takahashi; Sumiya Ishigami; Akihito Tsuji; Hidefumi Higashi; Toshihiko Nakamura; Hiroshi Saeki; Ken Shirabe; Yoshihiro Kakeji; Kenji Sakai; Hideo Baba; Tadashi Nishimaki; Shoji Natsugoe; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2015-08-11       Impact factor: 7.370

Review 10.  Clinical modalities for management of gastric cancer hepatic metastasis.

Authors:  Feng Tao; Jieqing Lv; Wei Wang; Ketao Jin
Journal:  Int J Clin Exp Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.